Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Guarneri

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
The Journal of Dermatological Treatment|September 25, 2018
Secukinumab for plaque psoriasis with ocular comorbidity: a clinical experienceSerafinella P Cannavò, Elisa Postorino, Emanuela Aragona, et al.
Frontiers in Pharmacology|April 22, 2022
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical TrialsVito Di Lernia, Laura Macca, Lucia Peterle, et al.
Wiener Medizinische Wochenschrift (1946)|May 7, 2014
Cancer, infection and disturbances of the integrity of tissue homeostasis: the most significant triggers for molecular mimicry and autoimmunity in dermatology?Georgi Tchernev, Torello Lotti, José-Carlos Cardoso, et al.
Mayo Clinic Proceedings|September 10, 2015
Fingolimod-Associated Peripheral Vascular Adverse EffectsMargherita Russo, Claudio Guarneri, Emanuela Mazzon, et al.
Frontiers in Medicine|July 24, 2023
Hidradenitis suppurativa and psoriasis: the odd coupleLaura Macca, Federica Li Pomi, Ylenia Ingrasciotta, et al.
Dermatology and Therapy|January 23, 2025
Management of Systemic Anti-psoriatic Drugs in Psoriasis Patients with Concurrent Paraplegia or Tetraplegia: Insights From a 6-Year Multicenter, Retrospective Observational StudyGiovanni Damiani, Alessia Pacifico, Stefano Ricciardi, et al.
Expert Opinion on Biological Therapy|March 6, 2024
Tildrakizumab: the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burdenPaolo Dapavo, Martina Burlando, Claudio Guarneri, et al.
Journal of Paediatrics and Child Health|May 23, 2006
Subcutaneous fat necrosis of the newborn: be aware of hypercalcaemiaFrancesco Borgia, Loredana De Pasquale, Caterina Cacace, et al.
Medicine|December 5, 2018
Hemangiomas of the tongue and the oral cavity in a myotonic dystrophy type 1 patient: A case reportSimona Portaro, Antonino Naro, Claudio Guarneri, et al.
The Lancet. Infectious Diseases|May 22, 2020
Silent COVID-19: what your skin can revealClaudio Guarneri, Emmanuele Venanzi Rullo, Piero Pavone, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Dermatological Treatment|September 25, 2018
Secukinumab for plaque psoriasis with ocular comorbidity: a clinical experienceSerafinella P Cannavò, Elisa Postorino, Emanuela Aragona, et al.
Frontiers in Pharmacology|April 22, 2022
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical TrialsVito Di Lernia, Laura Macca, Lucia Peterle, et al.
Wiener Medizinische Wochenschrift (1946)|May 7, 2014
Cancer, infection and disturbances of the integrity of tissue homeostasis: the most significant triggers for molecular mimicry and autoimmunity in dermatology?Georgi Tchernev, Torello Lotti, José-Carlos Cardoso, et al.
Mayo Clinic Proceedings|September 10, 2015
Fingolimod-Associated Peripheral Vascular Adverse EffectsMargherita Russo, Claudio Guarneri, Emanuela Mazzon, et al.
Frontiers in Medicine|July 24, 2023
Hidradenitis suppurativa and psoriasis: the odd coupleLaura Macca, Federica Li Pomi, Ylenia Ingrasciotta, et al.
Dermatology and Therapy|January 23, 2025
Management of Systemic Anti-psoriatic Drugs in Psoriasis Patients with Concurrent Paraplegia or Tetraplegia: Insights From a 6-Year Multicenter, Retrospective Observational StudyGiovanni Damiani, Alessia Pacifico, Stefano Ricciardi, et al.
Expert Opinion on Biological Therapy|March 6, 2024
Tildrakizumab: the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burdenPaolo Dapavo, Martina Burlando, Claudio Guarneri, et al.
Journal of Paediatrics and Child Health|May 23, 2006
Subcutaneous fat necrosis of the newborn: be aware of hypercalcaemiaFrancesco Borgia, Loredana De Pasquale, Caterina Cacace, et al.
Medicine|December 5, 2018
Hemangiomas of the tongue and the oral cavity in a myotonic dystrophy type 1 patient: A case reportSimona Portaro, Antonino Naro, Claudio Guarneri, et al.
The Lancet. Infectious Diseases|May 22, 2020
Silent COVID-19: what your skin can revealClaudio Guarneri, Emmanuele Venanzi Rullo, Piero Pavone, et al.
Pageof 18